12 completed, 1 unknown. 13 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 13 | Completed 12, Unknown 1 |
| Phase 2 | 3 | Completed 3 |
Follow Long-Term Synaptic Depression: new trials by email Literature Review of Long-Term Synaptic Depression trials Research Report on Long-Term Synaptic Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Iron Sucrose Injection in Healthy Participants Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues | Phase 1 | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 48 | 2024-11-22 | 2025-03-24 |
| Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues | Phase 1 | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 48 | 2024-06-25 | 2024-10-08 |
| Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd. - Bioequivalence, Schizophrenia | Phase 1 | Unknown | The Affiliated Hospital of Qingdao University | 100 | 2023-09-20 | 2023-10-04 |
| Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy Subjects Meloxicam Nanocrystal Injection(Yangtze River Pharmaceutical Group Co., Ltd.), Meloxicam Nanocrystal Injection (ANJESO®) - Pain | Phase 1 | Completed | Yangtze River Pharmaceutical Group Co., Ltd. | 20 | 2023-07-05 | 2026-06-29 |
| A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State Senaparib 10 mg strength capsules manufactured by WuXi STA (Wuxi) Co., Ltd., Senaparib 10 mg strength capsules manufactured by WuXi STA (Shanghai) Co., Ltd. - Solid Tumor | Phase 1 | Completed | Impact Therapeutics, Inc. | 32 | 2021-07-18 | 2025-06-22 |
| Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS recombinant human growth hormone, Saline - Phelan-McDermid Syndrome, Growth Hormone Treatment | Phase 1 / Phase 2 | Completed | Affiliated Hospital of Jiangnan University | 6 | 2020-06-14 | 2022-10-10 |
| Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Midazolam, Ketoconazole, Rifampicin - Healthy | Phase 1 | Completed | Seoul National University Hospital | 16 | 2012-12-01 | 2014-05-26 |
| A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children 3.50±0.25logCCID50/ml, 4.25±0.25 logCCID50/ml, 5.00±0.25 logCCID50/ml - Mumps | Phase 1 | Completed | Institute of Medical Biology, Chinese Academy of Medical Sciences | 300 | 2012-10-01 | 2023-10-10 |
| PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg Test-Bepotastine salicylate 9.64 mg, Reference-bepotastine besilate 10 mg - Allergic Rhinitis, Urticaria | Phase 1 | Completed | Korea University Anam Hospital | 26 | 2011-04-01 | 2013-07-12 |
| Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke Dl-3-n-butylphthalide, Cerebrolysin, Placebo - Acute Cerebral Stroke Within 12 Hours for the First Time | Phase 1 / Phase 2 | Completed | Shanghai 6th People's Hospital | 84 | 2010-01-01 | 2020-08-24 |
| Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China S-1, leucovorin, oxaliplatin - Colorectal Cancer | Phase 1 / Phase 2 | Completed | Shen Lin | 20 | 2009-09-01 | 2015-05-19 |
| Pharmacokinetic Comparisons of Two Donepezil Formulations Donepezil, ODT 10 mg, Donepezil, 10 mg tablet - Alzheimer Disease | Phase 1 | Completed | Korea University Anam Hospital | 22 | 2008-01-01 | 2011-02-16 |
| To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions Cilostazol 50 mg Tablets (Eon Pharma, LLC, USA), Pletal (Cilostazol) 50 mg Tablets (Otsuka Pharma Co, Ltd., USA) - Pain | Phase 1 | Completed | Sandoz | 26 | 2004-01-01 | 2017-03-28 |
Pain (2) · Alzheimer Disease (1) · Colorectal Neoplasms (1) · Ischemic Stroke (1) · Mumps (1) · Pruritus (1) · Rhinitis, Allergic (1) · Schizophrenia (1) · Telomeric 22q13 Monosomy Syndrome (1) · Urticaria (1)
Korea University Anam Hospital (2) · Sichuan Huiyu Pharmaceutical Co., Ltd (2) · Affiliated Hospital of Jiangnan University (1) · Impact Therapeutics, Inc. (1) · Institute of Medical Biology, Chinese Academy of Medical Sciences (1) · Sandoz (1) · Seoul National University Hospital (1) · Shanghai 6th People's Hospital (1) · Shen Lin (1) · The Affiliated Hospital of Qingdao University (1) · Yangtze River Pharmaceutical Group Co., Ltd. (1)
China (9) · South Korea (3)
Chuanling Li (1) · Chun Wan (1) · Gaetano Morelli, M.D. (1) · Ji-Young Park, MD, PhD (1) · Joo-Youn Cho, PhD (1) · Lixia Xue, M.D., Ph.D. (1) · YueYing Liu, Phd (1) · Yuliang Zhao, Master (1)
PMID 21723605, PMID 24105252, PMID 24614759, PMID 26158159, PMID 27168844, PMID 27317471